Carbox y Therapy
-
Upload
blair-eaton -
Category
Documents
-
view
20 -
download
4
description
Transcript of Carbox y Therapy
![Page 1: Carbox y Therapy](https://reader036.fdocuments.us/reader036/viewer/2022062718/56812ebf550346895d94610c/html5/thumbnails/1.jpg)
Carboxy Therapy
![Page 2: Carbox y Therapy](https://reader036.fdocuments.us/reader036/viewer/2022062718/56812ebf550346895d94610c/html5/thumbnails/2.jpg)
CARBOXITHERAPY
It is a non surgical method which consists of injecting CO2 at subcutaneous level through a very fine needle (3mm) by using an equipment especially designed for regulating the gas exit with a low pressure.
What is it?
![Page 3: Carbox y Therapy](https://reader036.fdocuments.us/reader036/viewer/2022062718/56812ebf550346895d94610c/html5/thumbnails/3.jpg)
Characteristics of CO2
Non scent, colorless, soluble in water
Final product of the organic metabolism
High disolution ( 20 times more than O2 in the microcirculation)
Modest transformation in HCO3
![Page 4: Carbox y Therapy](https://reader036.fdocuments.us/reader036/viewer/2022062718/56812ebf550346895d94610c/html5/thumbnails/4.jpg)
Origen of Carboxitherapy
1930 : France . Gas de Royat. Arteriopaties
1930 : Argentine Medical Association
1953: Publication of 20 experienced years with subcutaneous injections
![Page 5: Carbox y Therapy](https://reader036.fdocuments.us/reader036/viewer/2022062718/56812ebf550346895d94610c/html5/thumbnails/5.jpg)
Action mecanisms. Active Vaso-dilatation Increment of oxidatve phenomena Arteriolization of blood (Bohr
effect) Increasing of cellular oxygenation Lipolitic effect Sympatic-litic effect
![Page 6: Carbox y Therapy](https://reader036.fdocuments.us/reader036/viewer/2022062718/56812ebf550346895d94610c/html5/thumbnails/6.jpg)
Toxicity Absence of toxicity with high dose Absence of increment in the
systemic TA No variations in the systemic
partial pressure of O2 and CO2
![Page 7: Carbox y Therapy](https://reader036.fdocuments.us/reader036/viewer/2022062718/56812ebf550346895d94610c/html5/thumbnails/7.jpg)
Medical directions
Angiology: Arteriopaties, microangiopaties
Reumatology: Arthritis Urology: Erectil disfunction by
angiopaties Dermatology: Psoriasis, ulcers
related to microangiopaties.
![Page 8: Carbox y Therapy](https://reader036.fdocuments.us/reader036/viewer/2022062718/56812ebf550346895d94610c/html5/thumbnails/8.jpg)
Therapeutic directions
Vascular and artery pathologies Acute arthritis Sports Medicine Healing defects
![Page 9: Carbox y Therapy](https://reader036.fdocuments.us/reader036/viewer/2022062718/56812ebf550346895d94610c/html5/thumbnails/9.jpg)
Aesthetic indications
Cellulitis Located adiposity Pre liposculpture Pos lipoescuplture
![Page 10: Carbox y Therapy](https://reader036.fdocuments.us/reader036/viewer/2022062718/56812ebf550346895d94610c/html5/thumbnails/10.jpg)
Contraindications IAM, unstable anginas ICC HTA Acute tromboflebitis Located Infections Epilepsy Pregnancy Renal and respiratory insufficiencies
![Page 11: Carbox y Therapy](https://reader036.fdocuments.us/reader036/viewer/2022062718/56812ebf550346895d94610c/html5/thumbnails/11.jpg)
![Page 12: Carbox y Therapy](https://reader036.fdocuments.us/reader036/viewer/2022062718/56812ebf550346895d94610c/html5/thumbnails/12.jpg)
![Page 13: Carbox y Therapy](https://reader036.fdocuments.us/reader036/viewer/2022062718/56812ebf550346895d94610c/html5/thumbnails/13.jpg)
![Page 14: Carbox y Therapy](https://reader036.fdocuments.us/reader036/viewer/2022062718/56812ebf550346895d94610c/html5/thumbnails/14.jpg)
![Page 15: Carbox y Therapy](https://reader036.fdocuments.us/reader036/viewer/2022062718/56812ebf550346895d94610c/html5/thumbnails/15.jpg)
![Page 16: Carbox y Therapy](https://reader036.fdocuments.us/reader036/viewer/2022062718/56812ebf550346895d94610c/html5/thumbnails/16.jpg)
![Page 17: Carbox y Therapy](https://reader036.fdocuments.us/reader036/viewer/2022062718/56812ebf550346895d94610c/html5/thumbnails/17.jpg)
![Page 18: Carbox y Therapy](https://reader036.fdocuments.us/reader036/viewer/2022062718/56812ebf550346895d94610c/html5/thumbnails/18.jpg)
![Page 19: Carbox y Therapy](https://reader036.fdocuments.us/reader036/viewer/2022062718/56812ebf550346895d94610c/html5/thumbnails/19.jpg)
![Page 20: Carbox y Therapy](https://reader036.fdocuments.us/reader036/viewer/2022062718/56812ebf550346895d94610c/html5/thumbnails/20.jpg)
![Page 21: Carbox y Therapy](https://reader036.fdocuments.us/reader036/viewer/2022062718/56812ebf550346895d94610c/html5/thumbnails/21.jpg)
![Page 22: Carbox y Therapy](https://reader036.fdocuments.us/reader036/viewer/2022062718/56812ebf550346895d94610c/html5/thumbnails/22.jpg)
![Page 23: Carbox y Therapy](https://reader036.fdocuments.us/reader036/viewer/2022062718/56812ebf550346895d94610c/html5/thumbnails/23.jpg)
![Page 24: Carbox y Therapy](https://reader036.fdocuments.us/reader036/viewer/2022062718/56812ebf550346895d94610c/html5/thumbnails/24.jpg)
![Page 25: Carbox y Therapy](https://reader036.fdocuments.us/reader036/viewer/2022062718/56812ebf550346895d94610c/html5/thumbnails/25.jpg)
![Page 26: Carbox y Therapy](https://reader036.fdocuments.us/reader036/viewer/2022062718/56812ebf550346895d94610c/html5/thumbnails/26.jpg)
Treatment sessions
Between 15 and 20 sessions of approximately 10 minutes each, are suggested according to the different cases. The intensity per week is 2 or 3.
![Page 27: Carbox y Therapy](https://reader036.fdocuments.us/reader036/viewer/2022062718/56812ebf550346895d94610c/html5/thumbnails/27.jpg)
Treatment protocol
1. The suggested dose of CO2 per member should oscillate between 100 and 200 cc.
2. Divide the treated zone into 4 or 6 quadrants in eah member. It is suggested not to inject more than 30 o 50 cc per zone.
3. It is convenient to jab in several directions.
4. Injections should be complemented with manual massages to spread the gas, control the efisema and dicrease the annoyance on the patient
![Page 28: Carbox y Therapy](https://reader036.fdocuments.us/reader036/viewer/2022062718/56812ebf550346895d94610c/html5/thumbnails/28.jpg)
Clinic cases
Patient with multiple symmetrical lipomatosis; pre-surgery situation
(frontal)
Patient with multiple symmetrical lipomatosis; pre-surgery situation
(lateral)
![Page 29: Carbox y Therapy](https://reader036.fdocuments.us/reader036/viewer/2022062718/56812ebf550346895d94610c/html5/thumbnails/29.jpg)
. Patient with multiple symmetrical lipomatosis; pos-surgery situation
(frontal)
Patent with multiple symmetrical lipomatosis; pos surgery situation
(lateral)
Clinic cases
![Page 30: Carbox y Therapy](https://reader036.fdocuments.us/reader036/viewer/2022062718/56812ebf550346895d94610c/html5/thumbnails/30.jpg)
Microphotograph
Figure1. Microphotograph of the abdominal subcutaneous weave
on the patient with multiple symmetrical lipomatosis : biopsy before the treatment with CO2
Figure 2. Microphotography of the abdominal subcutaneous weave on the
patient with multiple symmetrical lipomatosis : biopsy after the treatment
with CO2. The areas of lisis adipocitaries are evident, with
conservation of the anatomic integrity of the vascular system.
![Page 31: Carbox y Therapy](https://reader036.fdocuments.us/reader036/viewer/2022062718/56812ebf550346895d94610c/html5/thumbnails/31.jpg)
Bibliography1. Hartmann B.R., Bassenge E., Pittler M.: «Effect of carbon
dioxide enriched water on the cutaneous mícrocirculation and oxygen tension in the skin of the foot». Angiology, 48, 957, 1997.
2. Klopstock T., Naumann M., Seibel P., et al.: «Mitocondrial DNA mutations in multiple Symmetric lipomatosis». Mol. Cell. Biochem., 17, 271, 1997.
3. Savin E., Bailliart O., Bonnin P., et al.: «Vasomotor effects of transcutaneous CO2 in stage. Il peripheral occlusive arterial disease». Angiology, 46, 785, 1995.
4. Smith P.D., Stadelmann W.K., Wassemann R.J., et al.: «Benign symmetric lipomatosis (Madelung's disease)». Ann. Plast. Surg., 41, 671, 1998.
Stavropoulos P.G., Wouboulis C.C., Trautmann C., et al.: «Symmetric lipomatoses in female patients». Dermatology, 194, 26, 1997.
![Page 32: Carbox y Therapy](https://reader036.fdocuments.us/reader036/viewer/2022062718/56812ebf550346895d94610c/html5/thumbnails/32.jpg)
THANKS FOR YOUR ATENTION